| Cat. No. |
Product Name |
Information |
| PC-72735 |
MCULE-5948770040
SARS-CoV-2 Mpro inhibitor
|
MCULE-5948770040 is a competitive noncovalent inhibitor of SARS-CoV-2 main protease (Mpro) with IC50 of 0.68 uM. |
| PC-72607 |
PF-07321332
SARS-CoV-2 Mpro inhibitor
|
PF-07321332 (Nirmatrelvir, Paxlovid) is the first, orally bioavailable SARS-CoV-2 main protease (Mpro) inhibitor with biochemical Ki of 3.11 nM. |
| PC-72518 |
Jun9-57-3R
Mpro inhibitor
|
Jun9-57-3R is a potent, selective, covalent SARS-CoV-2 Mpro inhibitor with IC50 of 0.05 uM. |
| PC-72517 |
Jun9-88-6R
Mpro inhibitor
|
Jun9-88-6R is a potent, selective, covalent SARS-CoV-2 Mpro inhibitor with IC50 of 0.08 uM. |
| PC-72516 |
Jun9-62-2R
Mpro inhibitor
|
Jun9-62-2R is a potent, selective, covalent SARS-CoV-2 Mpro inhibitor with IC50 of 0.43 uM. |
| PC-72437 |
MPI3
SARA-CoV2 Mpro inhibitor
|
MPI8 is a highly potent SARS-CoV-2 main protease (MPro) inhibitor with IC50 of 8.5 nM. |
| PC-72436 |
MPI5
SARA-CoV2 Mpro inhibitor
|
MPI8 is a highly potent SARS-CoV-2 main protease (MPro) inhibitor with IC50 of 33 nM, completely prevented the SARS-CoV-2-induced cytopathogenic effect in Vero E6 cells at 2.5-5 uM and A549 cells at 0.16-0.31 uM. |
| PC-72328 |
NSC 621601
SARS-CoV-2 entry inhibitor
|
NSC 621601 (Compound Q34) is a potent, specific inhibitor of SARS-CoV-2 cellular entry with IC50 of 15 uM. |
| PC-72204 |
3CLpro inhibitor 6j
3CLpro inhibitor
|
3CLpro inhibitor 6j (GC376 analog 6j) is a potent, selective inhibitor of Coronavirus 3C-like proteases (3CLpro) with IC50 of 0.08, 1.2, and 0.48 uM against MERS-CoV, SARS-CoV, and SARS-CoV-2 FRET 3CLpro in enzyme assays, respectively. |
| PC-72202 |
SARS-CoV-2 Mpro inhibitor 11b
SARS-CoV-2 Mpro inhibitor
|
SARS-CoV-2 Mpro inhibitor 11b is a potent, selective SARS-CoV-2 Mpro inhibitor with IC50 of 40 nM. |
| PC-72201 |
MI-30
SARS-CoV-2 Mpro inhibitor
|
MI-30 (SARS-CoV-2 Mpro inhibitor MI-30) is a potent, selective SARS-CoV-2 Mpro inhibitor with IC50 of 17.2 nM. |
| PC-72200 |
MI-09
SARS-CoV-2 Mpro inhibitor
|
MI-09 (SARS-CoV-2 Mpro inhibitor MI-09) is a potent, selective SARS-CoV-2 Mpro inhibitor with IC50 of 15.2 nM. |
